Abalos Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $49M

  • Investors
  • 8

Abalos Therapeutics General Information

Description

Developer of an immuno-virotherapy platform designed to facilitate the treatment of solid tumors. The company's technology utilizes arenaviruses, viral replication, and systemic administration to provide innate immune activation, adaptive response triggering, and tumor uncloaking, enabling oncology patients to combat primary tumors and distant metastases through a concerted immune system attack from within the tumor.

Contact Information

Formerly Known As
RM 1901 Vermögensverwaltungs, Virolutions Biotech
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Merowingerplatz 1 A
  • 40225 Dusseldorf
  • Germany
+49 0211
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Merowingerplatz 1 A
  • 40225 Dusseldorf
  • Germany
+49 0211

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abalos Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 14-Oct-2021 $49M Completed Pre-Clinical Trials
To view Abalos Therapeutics’s complete valuation and funding history, request access »

Abalos Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an immuno-virotherapy platform designed to facilitate the treatment of solid tumors. The company's technolo
Drug Discovery
Dusseldorf, Germany
23 As of 2026

Lexington, MA
 

Somerville, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Abalos Therapeutics Competitors (2)

One of Abalos Therapeutics’s 2 competitors is Agenus, a Formerly VC-backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agenus Formerly VC-backed Lexington, MA
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
You’re viewing 2 of 2 competitors. Get the full list »

Abalos Therapeutics Patents

Abalos Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026185313-A1 Virus particles for the treatment of cancer Pending 05-Mar-2025
AU-2024330299-A1 Virus particles with improved entry into tumor cells Pending 31-Aug-2023
EP-4771132-A1 Virus particles with improved entry into tumor cells Pending 31-Aug-2023
WO-2025046106-A1 Virus particles with improved entry into tumor cells Inactive 31-Aug-2023
AU-2022226407-A1 New virus particles for therapeutic purposes Pending 26-Feb-2021 C12N7/00
To view Abalos Therapeutics’s complete patent history, request access »

Abalos Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abalos Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boehringer Ingelheim Venture Fund Corporate Venture Capital Minority
Coparion Venture Capital Minority
Gründerfonds Ruhr Venture Capital Minority
High-Tech Gründerfonds Venture Capital Minority
Hx Bio Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Abalos Therapeutics FAQs

  • When was Abalos Therapeutics founded?

    Abalos Therapeutics was founded in 2019.

  • Where is Abalos Therapeutics headquartered?

    Abalos Therapeutics is headquartered in Dusseldorf, Germany.

  • What is the size of Abalos Therapeutics?

    Abalos Therapeutics has 23 total employees.

  • What industry is Abalos Therapeutics in?

    Abalos Therapeutics’s primary industry is Drug Discovery.

  • Is Abalos Therapeutics a private or public company?

    Abalos Therapeutics is a Private company.

  • What is the current valuation of Abalos Therapeutics?

    The current valuation of Abalos Therapeutics is .

  • What is Abalos Therapeutics’s current revenue?

    The current revenue for Abalos Therapeutics is .

  • How much funding has Abalos Therapeutics raised over time?

    Abalos Therapeutics has raised $49M.

  • Who are Abalos Therapeutics’s investors?

    Boehringer Ingelheim Venture Fund, Coparion, Gründerfonds Ruhr, High-Tech Gründerfonds, and Hx Bio Ventures are 5 of 8 investors who have invested in Abalos Therapeutics.

  • Who are Abalos Therapeutics’s competitors?

    Agenus and Genetix Biotherapeutics are competitors of Abalos Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process